2021 annual financial data
Corbus Pharmaceuticals Holdings 2021 Operating margin
Direct answer
Operating margin was -6,350.09%.
Operating income was -55,989,024 USD and net income was -45,552,588 USD.
Operating cash flow was -48,183,697 USD.
Get free Corbus Pharmaceuticals Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 881,705 USD
- Operating income
- -55,989,024 USD
- Net income
- -45,552,588 USD
- Operating cash flow
- -48,183,697 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Corbus Pharmaceuticals Holdings financial years